Evidence map›Paper›PMID 34956097›Full record

ArticleFrontiers in endocrinology2021

Elevated Anti-Müllerian Hormone Is an Independent Risk Factor for Preterm Birth Among Patients With Overweight Polycystic Ovary Syndrome.

Mingze Du, Junwei Zhang, Xiaona Yu, Yichun Guan

Open access · goldAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Mingze DuThe Reproductive Center, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Junwei ZhangThe Reproductive Center, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Xiaona YuThe Reproductive Center, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Yichun GuanThe Reproductive Center, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Third Affiliated Hospital of Zhengzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To explore whether elevated anti-Müllerian hormone (AMH) levels affect the rate of preterm birth (PTB) among PCOS patients with different BMIs. Methods: In this retrospective cohort study, patients with PCOS who had undergone IVF/ICSI from January 2017 to December 2019 were included for potential evaluation. A total of 2368 singleton live births from PCOS patients were included. According to the BMI, all the PCOS patients were divided into two groups: BMI<24 kg/m Results: Regarding PCOS patients with a BMI<24 kg/m Conclusion: For PCOS patients, a BMI≥24 kg/m

Indexed as

AdultAnti-Mullerian HormoneBiomarkersCohort StudiesFemaleHumansInfant, NewbornOverweightPolycystic Ovary SyndromePregnancyPremature BirthRetrospective StudiesRisk FactorsAnti-Mullerian HormoneBiomarkersanti-Müllerian hormonebody mass indexin vitro fertilizationpolycystic ovary syndromepreterm birth

Identifiers

PMID34956097
PMCPMC8692368
OpenAlexW4200021154

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.